Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 11-Mar-22 4:22 PM View:  | Arena Pharmaceuticals, Inc. (ARNA) | 11-Mar-22 | Disposition (other) | 7,152 | -- | -- | (100%) 7.15K to 0 | |
| 15-Jun-21 5:27 PM View: | Arena Pharmaceuticals, Inc. (ARNA) | 15-Jun-21 | Market Sale (Planned) | 1,223 | $66.36 | $81,158.30 | (15%) 8.38K to 7.15K | |
| 15-Jun-21 5:27 PM View: | Arena Pharmaceuticals, Inc. (ARNA) | 11-Jun-21 | Grant | 3,067 | -- | -- | 58% 5.31K to 8.38K | |
| 20-Jan-21 9:06 PM View: | Arena Pharmaceuticals, Inc. (ARNA) | 19-Jan-21 | Market Sale (Planned) | 1,327 | $80.50 | $106,824.00 | (20%) 6.63K to 5.31K | (< 1%) |
| 15-Dec-20 4:07 PM View: | Arena Pharmaceuticals, Inc. (ARNA) | 11-Dec-20 | Market Purchase | 5 | $69.31 | $346.55 | < 1% 6.63K to 6.63K | 9% |
| 09-Dec-20 4:03 PM View: | Arena Pharmaceuticals, Inc. (ARNA) | 08-Dec-20 | Market Purchase | 5 | $66.25 | $331.24 | < 1% 6.63K to 6.63K | 14% |
| 14-Oct-20 4:15 PM View: | Aimmune Therapeutics, Inc. (AIMT) | 13-Oct-20 | Disposition | 89,250 | $34.50 | $3,079,120.00 | (100%) 89.25K to 0 | |
| 14-Oct-20 4:15 PM View: | Aimmune Therapeutics, Inc. (AIMT) | 10-Oct-20 | Disposition (change in control) | 30,422 | $34.50 | $1,049,560.00 | (100%) 30.42K to 0 | |
| 16-Sep-20 5:17 PM View: | Aimmune Therapeutics, Inc. (AIMT) | 15-Sep-20 | Payment of Exercise | 1,642 | $34.25 | $56,238.50 | (1%) 118.68K to 117.03K | |
| 26-Jun-20 5:06 PM View: | Aimmune Therapeutics, Inc. (AIMT) | 22-Jun-20 | Payment of Exercise | 7,907 | $18.02 | $142,484.00 | (6%) 126.58K to 118.68K | (12%) |
| 16-Jun-20 7:40 PM View: | Arena Pharmaceuticals, Inc. (ARNA) | 12-Jun-20 | Grant | 2,446 | -- | -- | 59% 4.18K to 6.63K | |
| 12-May-20 5:25 PM View: | Aimmune Therapeutics, Inc. (AIMT) | 10-May-20 | Grant | 3,300 | -- | -- | 3% 123.28K to 126.58K | |
| 10-Mar-20 8:48 PM View: | Aimmune Therapeutics, Inc. (AIMT) | 10-Mar-20 | Market Purchase | 2,665 | $18.74 | $49,934.10 | 2% 120.62K to 123.28K | 8% |
| 04-Mar-20 9:42 PM View: | Aimmune Therapeutics, Inc. (AIMT) | 02-Mar-20 | Payment of Exercise | 3,081 | $23.81 | $73,358.60 | (2%) 123.7K to 120.62K | |
| 03-Mar-20 8:37 PM View: | Aimmune Therapeutics, Inc. (AIMT) | 28-Feb-20 | Grant | 33,000 | -- | -- | 36% 90.7K to 123.7K | |
| 14-Feb-20 10:00 PM View: | Aimmune Therapeutics, Inc. (AIMT) | 19-Jun-19 | Payment of Exercise | 7,951 | $20.20 | $160,610.00 | (8%) 98.65K to 90.7K | (< 1%) |
| 17-Jun-19 6:38 PM View: | Arena Pharmaceuticals, Inc. (ARNA) | 14-Jun-19 | Market Sale (Planned) | 1,525 | $55.90 | $85,240.30 | (27%) 5.7K to 4.18K | (35%) |
| 17-Jun-19 6:38 PM View: | Arena Pharmaceuticals, Inc. (ARNA) | 13-Jun-19 | Grant | 2,654 | -- | -- | 87% 3.05K to 5.7K | |
| 26-Feb-19 10:00 PM View: | Aimmune Therapeutics, Inc. (AIMT) | 22-Feb-19 | Grant | 35,000 | -- | -- | 55% 63.65K to 98.65K | |
| 19-Nov-18 8:12 PM View: | Aimmune Therapeutics, Inc. (AIMT) | 19-Nov-18 | Market Purchase | 3,650 | $27.56 | $100,587.00 | 6% 60.0K to 63.65K | (12%) |
| 19-Jun-18 7:06 PM View: | Aimmune Therapeutics, Inc. (AIMT) | 19-Jun-18 | Grant | 60,000 | -- | -- | 100% 0 to 60.0K | |
| 15-Jun-18 4:29 PM View: | Arena Pharmaceuticals, Inc. (ARNA) | 13-Jun-18 | Grant | 3,050 | -- | -- | 100% 0 to 3.05K | |
| 04-Jun-18 4:50 PM View: | Ultragenyx Pharmaceutical I... (RARE) | 01-Jun-18 | Payment of Exercise | 294 | $73.73 | $21,676.60 | (1%) 24.12K to 23.83K | (134%) |
| 19-Apr-18 4:46 PM View: | Ultragenyx Pharmaceutical I... (RARE) | 19-Apr-18 | Grant | 1,431 | -- | -- | 6% 22.17K to 23.6K | |
| 05-Mar-18 4:19 PM View: | Ultragenyx Pharmaceutical I... (RARE) | 01-Mar-18 | Grant | 6,500 | -- | -- | 40% 16.11K to 22.61K | |
| 05-Mar-18 4:19 PM View: | Ultragenyx Pharmaceutical I... (RARE) | 01-Mar-18 | Payment of Exercise | 441 | $48.43 | $21,357.60 | (2%) 22.61K to 22.17K | (257%) |
| 07-Aug-17 4:54 PM View: | Ultragenyx Pharmaceutical I... (RARE) | 03-Aug-17 | Payment of Exercise | 940 | $62.59 | $58,834.60 | (6%) 17.05K to 16.11K | (176%) |
| 01-Jun-17 9:18 PM View: | Ultragenyx Pharmaceutical I... (RARE) | 01-Jun-17 | Payment of Exercise | 320 | $56.61 | $18,115.20 | (2%) 17.37K to 17.05K | (205%) |
| 01-Mar-17 5:36 PM View: | Ultragenyx Pharmaceutical I... (RARE) | 01-Mar-17 | Grant | 4,500 | -- | -- | 36% 12.46K to 16.96K | |
| 08-Aug-16 4:01 PM View: | Ultragenyx Pharmaceutical I... (RARE) | 04-Aug-16 | Payment of Exercise | 940 | $64.24 | $60,385.60 | (7%) 13.4K to 12.46K | (145%) |
| 03-Jun-16 4:12 PM View: | Ultragenyx Pharmaceutical I... (RARE) | 01-Jun-16 | Grant | 3,400 | -- | -- | 34% 10.0K to 13.4K | |
| 06-Aug-15 5:40 PM View: | Ultragenyx Pharmaceutical I... (RARE) | 04-Aug-15 | Grant | 10,000 | -- | -- | 100% 0 to 10.0K |